Terms: = Lung cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
50 results:
1. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma.
Dal Lago EA; Sousa LG; Yang Z; Hoff CO; Bonini F; Sawyer M; Wang K; Lewis W; Wahid KA; Hanna EY; El-Naggar A; Fuller CD; Kundu S; Godoy M; Ferrarotto R
Oral Oncol; 2024 Apr; 151():106759. PubMed ID: 38507991
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma.
Liu J; Zhu L; Tang M; Huang X; Gu C; He C; Lv X; Hu J
Sci Rep; 2024 Mar; 14(1):5523. PubMed ID: 38448498
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
[TBL] [Abstract] [Full Text] [Related]
4. Bidirectional Association Between Cardiovascular Disease and lung cancer in a Prospective Cohort Study.
Zhang S; Liu L; Shi S; He H; Shen Q; Wang H; Qin S; Chang J; Zhong R
J Thorac Oncol; 2024 Jan; 19(1):80-93. PubMed ID: 37703998
[TBL] [Abstract] [Full Text] [Related]
5. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
[TBL] [Abstract] [Full Text] [Related]
6. Clinical effect of surgical treatment for lung metastasis and prognostic risk factor analysis: a single-centred cohort study.
Peng D; Sun W
ANZ J Surg; 2023 Jun; 93(6):1551-1558. PubMed ID: 37226585
[TBL] [Abstract] [Full Text] [Related]
7. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell lung cancer: A Study Using Data from the Korean Nationwide lung cancer Registry.
Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
[TBL] [Abstract] [Full Text] [Related]
8. Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model.
Zhao M; Shao T; Chi Z; Tang W
Front Public Health; 2023; 11():1051484. PubMed ID: 36908446
[TBL] [Abstract] [Full Text] [Related]
9. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract] [Full Text] [Related]
10. Dual-vessel intervention treatment for massive hemoptysis caused by lung cavitary lesions.
Yang Q; Cheng Luo L; Wei H; Yi Q; Luo W
Eur J Radiol; 2022 Sep; 154():110448. PubMed ID: 35917756
[TBL] [Abstract] [Full Text] [Related]
11. Active breathing control guided stereotactic body ablative radiotherapy for management of liver metastases from colorectal cancer.
Gamsiz H; Sager O; Uysal B; Dincoglan F; Demiral S; Colak O; Ozcan F; Dirican B; Beyzadeoglu M
Acta Gastroenterol Belg; 2022; 85(3):469-475. PubMed ID: 35770280
[TBL] [Abstract] [Full Text] [Related]
12. Atezolizumab for Pretreated Non-Small Cell lung cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.
Ikeda S; Kato T; Kenmotsu H; Ogura T; Sato Y; Hino A; Harada T; Kubota K; Tokito T; Okamoto I; Furuya N; Yokoyama T; Hosokawa S; Iwasawa T; Kasajima R; Miyagi Y; Misumi T; Okamoto H
Oncologist; 2022 Sep; 27(9):720-e702. PubMed ID: 35759340
[TBL] [Abstract] [Full Text] [Related]
13. GSTP1
Walia HK; Singh N; Sharma S
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S739-S752. PubMed ID: 34780261
[TBL] [Abstract] [Full Text] [Related]
14. lung Dose Measured on Postradioembolization
Stella M; van Rooij R; Lam MGEH; de Jong HWAM; Braat AJAT
J Nucl Med; 2022 Jul; 63(7):1075-1080. PubMed ID: 34772794
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma.
Zhang H; Shan G; Cai B; Bi G; Chen Z; Liang J; Besskaya V; Zheng Y; Guo W; Wang L; Xu S; Zhan C
Thorac Cancer; 2021 Nov; 12(22):3011-3018. PubMed ID: 34596344
[TBL] [Abstract] [Full Text] [Related]
16. Veliparib in Combination With Platinum-Based Chemotherapy for First-Line treatment of Advanced Squamous Cell lung cancer: A Randomized, Multicenter Phase III Study.
Ramalingam SS; Novello S; Guclu SZ; Bentsion D; Zvirbule Z; Szilasi M; Bernabe R; Syrigos K; Byers LA; Clingan P; Bar J; Vokes EE; Govindan R; Dunbar M; Ansell P; He L; Huang X; Sehgal V; Glasgow J; Bach BA; Mazieres J
J Clin Oncol; 2021 Nov; 39(32):3633-3644. PubMed ID: 34436928
[TBL] [Abstract] [Full Text] [Related]
17. Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell lung cancer: A Phase 2 Randomized Trial.
Qiu B; Wang D; Li Q; Wu Y; Guo S; Jiang X; Fang J; Guo J; Liu F; Chu C; Wang B; Chen L; Zhang J; Liu Y; Hu Y; Liu H
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):917-925. PubMed ID: 34229051
[TBL] [Abstract] [Full Text] [Related]
18. Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Cortellini A; Cannita K; Tiseo M; Cortinovis DL; Aerts JGJV; Baldessari C; Giusti R; Ferrara MG; D'Argento E; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Antonuzzo L; Mazzoni F; De Toma A; Signorelli D; Gelibter A; Targato G; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; Mansueto G; Zoratto F; Filetti M; Bracarda S; Citarella F; Russano M; Cantini L; Nigro O; Buti S; Minuti G; Landi L; Ricciardi S; Migliorino MR; Natalizio S; Simona C; De Filippis M; Metro G; Adamo V; Russo A; Spinelli GP; Di Maio M; Banna GL; Friedlaender A; Addeo A; Pinato DJ; Ficorella C; Porzio G
Eur J Cancer; 2021 May; 148():24-35. PubMed ID: 33721704
[TBL] [Abstract] [Full Text] [Related]
19. Volume-based algorithm of lung dose optimization in novel dynamic arc radiotherapy for esophageal cancer.
Lin KH; Hsu CX; Wang SY; Mok GSP; Chang CH; Tien HJ; Shueng PW; Wu TH
Sci Rep; 2021 Feb; 11(1):4360. PubMed ID: 33623071
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort.
Rumpold H; Kirchweger P; Niedersüß-Beke D; Falch D; Wundsam H; Metz-Gercek S; Piringer G; Thaler J
Acta Oncol; 2021 Feb; 60(2):180-186. PubMed ID: 33095652
[TBL] [Abstract] [Full Text] [Related]
[Next]
